InMed Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. InMed Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11% to $4,597,730. The net income raised on -$7,675,550 and profit margin reached -167%. Total operating expenses were $9,015,743,000.
Profit Margin
| 2014 | 0 | -1.15M | |
|---|---|---|---|
| 2015 | 0 | -3.45M | |
| 2016 | 0 | -1.83M | |
| 2017 | 0 | -3.43M | |
| 2018 | 0 | -6.47M | |
| 2019 | 0 | -10.09M | |
| 2020 | 0 | -8.94M | |
| 2021 | 0 | -10.20M | |
| 2023 | 4.13M | -7.94M | -192.18% |
| 2024 | 4.59M | -7.67M | -166.94% |
IN.TO Income Statement (2014 – 2024)
| 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 4.59M | 4.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 6.99B | 2.73M | 0 | 183.09K | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | -6.98B | 1.40M | 0 | -183.09K | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 3.76B | 3.73M | 5.33M | 5.20M | 4.29M | 1.46M | 573.72K | 292.84K | 759.85K | 57.87K |
Selling and marketing | 0 | 0 | 0 | 474.94K | 706.22K | 1.04M | 844.27K | 112.64K | 498.43K | 22.65K |
Total operating expenses | 9.01B | 9.78M | 9.93M | 8.86M | 10.39M | 6.54M | 3.43M | 1.83M | 3.45M | 1.15M |
Operating income | 0 | -8.17B | -9.93M | -8.74M | -10.39M | -6.54M | -3.43M | -1.83M | -3.45M | -1.15M |
Other income (expenses), net | 246.38M | 588.53K | -264.80K | 60.73K | 296.27K | 67.38K | -495 | -23 | -3.52K | -1.69K |
Income before tax | -7.66M | -7.93M | -10.20M | -8.68M | -10.09M | -6.47M | -3.43M | -1.83M | -3.45M | -1.15M |
Income tax expense | 7.1K | 13.1K | 95.54K | 18.61K | 296.27K | 67.38K | 495 | -23 | 3.52K | 1.69K |
Net income | -7.67M | -7.94M | -10.20M | -8.94M | -10.09M | -6.47M | -3.43M | -1.83M | -3.45M | -1.15M |
Earnings per share | ||||||||||
Basic EPS | -1.01 | -3.25 | -1.95 | -42.57 | -1.94 | -1.5 | -31.73 | -1.01 | -61.89 | -27.48 |
Diluted EPS | -1.01 | -3.25 | -1.95 | -42.57 | -1.94 | -1.5 | -31.73 | -1.01 | -61.89 | -27.48 |
| Data source | Data source | Data source | Data source | Data source | Data source |